Touchlight
Developer of enzymatic DNA technologies designed to enable genetic medicines including viral vector production, mRNA and
Discovery Tools (Healthcare)
📍 Hampton, United Kingdom
Founded 2007
Current Valuation
$704.39M
as of 2021-Q3
PRIVATE
Developer of enzymatic DNA technologies designed to enable genetic medicines including viral vector production, mRNA and DNA based therapies and vaccines.
Company Profile
HQ
Hampton, United Kingdom
Last Round
Later Stage VC — $126.67M (Sep 2021)
Fundraising Status
Later Stage VC · $126.67M · 4y 11mo ago
privateTotal raised $198.91M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Later Stage VC | $126.67M | Sep 2021 | — | $704.39M |
MedicalHealth CareBiotechnologyBiopharma
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q3. Refreshed quarterly.